About University College Hospital Macmillan Cancer Centre
UCH Macmillan Cancer Centre is a research-led day hospital in Huntley Street in central London. It is the oncology wing of University College Hospital, part of the University College London Hospitals NHS Foundation Trust.
Clinical Trials at University College Hospital Macmillan Cancer Centre
During the past decade, University College Hospital Macmillan Cancer Centre conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University College Hospital Macmillan Cancer Centre"
#1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at University College Hospital Macmillan Cancer Centre
According to Clinical.Site data, the most researched conditions in "University College Hospital Macmillan Cancer Centre" are
"Carcinoma" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Solid and Hematological Malignancies" (1 trials). Many other conditions were trialed in "University College Hospital Macmillan Cancer Centre" in a lesser frequency.
Clinical Trials Intervention Types at University College Hospital Macmillan Cancer Centre
Most popular intervention types in "University College Hospital Macmillan Cancer Centre" are "Drug" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Autologous Genetically modified T cells, MAGEA10ᶜ⁷⁹⁶T" (1 trials), "Bendamustine" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials) and "JCAR017" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University College Hospital Macmillan Cancer Centre
The vast majority of trials in "University College Hospital Macmillan Cancer Centre" are
4 trials for "All" genders.
Clinical Trials Status at University College Hospital Macmillan Cancer Centre
Currently, there are NaN active trials in "University College Hospital Macmillan Cancer Centre".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University College Hospital Macmillan Cancer Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University College Hospital Macmillan Cancer Centre, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".